Reference
Smyth L, et al. Economic Impact of 21-gene Recurrence Score testing on Early Stage Breast Cancer in Ireland. Internet Document : 24 Mar 2015. Available from: URL: http://www.poster-submission.com/search/sresult
Rights and permissions
About this article
Cite this article
Oncotype DX testing directs therapy and saves costs in Ireland. PharmacoEcon Outcomes News 725, 23 (2015). https://doi.org/10.1007/s40274-015-2037-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2037-6